Community post

Xiaolin Hou (Chinese Academy of Sciences) and colleagues published a new paper on advances in engineered phages for disease treatment, showing recent progress in enhancing phage targeting, stability, and synergistic combinations, across antibacterial therapy, tumor therapy, and vaccine development.